Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 21, 2018
Accession Number:
0001104659-18-052106
Submission Type:
POS AM
CIK:
0001005201
Company Name:
Assertio Therapeutics, Inc
File Number:
333-223420